MEDIMEL
ActiveSummary
MEDIMEL has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €6k and a net result of €51k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 8% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
71
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability99▼-1
Solvency28▼-72
Growth58▼-20
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
2.8%
Return on assets
23.9%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 8% of 16546 sector peers (2025).
NBB · sector comparisonPosition among 16546 sector peers
Solvency
better than 8%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-04-2026, 94 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
94 d early
2024
9 d early
2023
30 d late
2022
148 d late
2021
96 d late
2020
61 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€6k▼ 95.9%
2024 · €147k
2020: €34k
2021: €125k
2022: €215k
2023: €97k
2024: €147k
2020 → 2025
Total assets
€212k▲ 26.8%
2024 · €167k
2020: €58k
2021: €141k
2022: €229k
2023: €206k
2024: €167k
2020 → 2025
Net result
€51k▲ 2.2%
2024 · €50k
2020: €28k
2021: €91k
2022: €90k
2023: €63k
2024: €50k
2020 → 2025
Working capital
€4k▼ 97.1%
2024 · €135k
2020: €20k
2021: €111k
2022: €206k
2023: €83k
2024: €135k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€125k-€215k▲ 71.6%€97k▼ 54.6%€147k▲ 51.0%€6k▼ 95.9%
Operating result€116k-€114k▼ 1.7%€76k▼ 33.2%€61k▼ 19.3%€65k▲ 6.1%
Net result€91k-€90k▼ 1.2%€63k▼ 29.8%€50k▼ 21.0%€51k▲ 2.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 6% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €212k
Fixed assets
€2k ▼ 82.2%
Current assets
€210k ▲ 35.0%
Equity and liabilities €212k
Equity
€6k ▼ 95.9%
Debt
€206k ▲ 913%
Debt's share of the balance-sheet total rises from 12.2% to 97.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€66k▲
2024 · €65k
Cash flow
€52k▼
2024 · €54k
Current ratio
1.02▼
2024 · 7.65
Debt to equity
34.36▲
2024 · 0.14
ROE
845.2%▲
2024 · 33.8%
ROA
23.9%▼
2024 · 29.7%
Interest coverage
469.25▼
2024 · 914.54
Debt ≤ 1 year
€206k▲
2024 · €20k
Income taxes
€14k▲
2024 · €14k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet
Code20242025
Assets
Total assets20/58€167k€212k▲
Fixed assets21/28€12k€2k▼
Tangible fixed assets22/27€12k€2k▼
Plant, machinery and equipment23€496€0▼
Furniture and vehicles24€11k€2k▼
Current assets29/58€156k€210k▲
Amounts receivable within one year40/41€105k€71k▼
Trade receivables40€0€6k▲
Other amounts receivable41€105k€64k▼
Cash at bank and in hand54/58€49k€138k▲
Deferred charges and accrued income490/1€2k€2k▼
Equity and liabilities
Total equity and liabilities10/49€167k€212k▲
Equity10/15€147k€6k▼
Contributions10/11€6k€6k=
Reserves13€141k€0▼
Distributable reserves133€141k€0▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€20k€206k▲
Amounts payable within one year42/48€20k€206k▲
Financial debts43€0-
Credit institutions430/8€0-
Trade debts44€538€2k▲
Suppliers440/4€538€2k▲
Advances received on contracts in progress46€4k€9k▲
Taxes, remuneration and social security45€1k€29k▲
Taxes450/3€1k€29k▲
Other amounts payable47/48€15k€166k▲
Income statement
Code20242025
Remuneration, social security and pensions62€0-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€2k▼
Other operating charges640/8€2k€2k▼
Non-recurring operating charges66A-€55
Gross operating margin9900€67k€68k▲
Operating profit (loss)9901€61k€65k▲
Financial income75/76B€2k€0▼
Recurring financial income75€2k€0▼
Financial charges65/66B€72€142▲
Recurring financial charges65€72€142▲
Profit (loss) for the period before taxes9903€63k€65k▲
Income taxes67/77€14k€14k▲
Profit (loss) for the period9904€50k€51k▲
Profit (loss) for the period to be appropriated9905€50k€51k▲
Appropriation of the result
Profit (loss) to be appropriated9906€50k€51k▲
Profit (loss) brought forward from the previous period14P€0-
Transfer from equity791/2-€141k
Transfer to equity691/2€50k€0▼
To other reserves6921€50k€0▼
Profit to be distributed694/7€0€192k▲
Return on contributions (dividend)694€0€192k▲
The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
22-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity quadruplescurrent ratio 7.65
Current ratio from 1.76 to 7.65; short-term debt falls from €109k to €20k.
31-12
Financial
Equity above €100kEq €147k ▲51%
5 profitable years in a row build equity to €147k.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
26-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 148 days late
2022
31-12
Financial
Equity above €200kEq €215k ▲71.6%
3 profitable years in a row build equity to €215k.
04-11
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 96 days late
2021
31-12
Financial
Highest result since 2020net €91k ▲219%
Operating result €116k, net result €91k, both a record.
31-12
Financial
Liquidity times 5current ratio 8.38
Current ratio from 1.86 to 8.38; short-term debt falls from €23k to €15k.
31-12
Financial
Equity above €100kEq €125k ▲263%
2 profitable years in a row build equity to €125k.
30-09
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 61 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schoten · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Schijnparklaan 312900 SchotenGround area
1,973 m²
Building footprint
162 m²
Volume, LiDAR
846 m³
Parcel 11040D0346/00M000, Flanders · tallest building 12.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
MEDIMEL
since 20202.307.880.220
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11040D0346/00M000 | Flanders | 1,973 m² | 1 · 162 m² | 12.1 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. VANDERSPICKKEN FREDERIQUE
BE 0733.952.874
Genk · Eq €6,000
Dr. J. Brulmans, huisarts
BE 0738.405.174
Boechout · Eq €6,000
Cabinet Médical Antoine EVRARD
BE 0744.521.916
Chaudfontaine · Eq €6,000
Dokter Sofie De Becker, Huisarts
BE 0745.790.735
Duffel · Eq €6,000
Dr. Miek Smeets
BE 0754.582.497
Antwerpen · Eq €6,000
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 1,542 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-09-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.